🇺🇸 FDA
Patent

US 7816075

Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents

granted A61KA61K31/00A61K31/201

Quick answer

US patent 7816075 (Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents) held by Xenon Pharmaceuticals Inc. expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Pharmaceuticals Inc.
Grant date
Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/00, A61K31/201, A61K31/426, A61K31/4439